Skip to content

Copper Shapes T Cell Metabolism and Epigenetics to Drive Pathogenic Th17 Cell Function in Autoimmunity 2259915

Jul 2026 · Journal of Immunology · Vol 215 · 0 citations

Abstract

Pathogenic T helper 17 (pTh17) cells are a subset of CD4+ T cells driving autoimmune diseases including multiple sclerosis (MS). To identify transporters controlling pTh17 cells, we conducted an in vivo shRNA-based forward genetic screen using the experimental autoimmune encephalomyelitis (EAE) model of MS. Copper Transporter 1 (CTR1), essential for copper uptake, emerged as a key regulator of pTh17 cell differentiation and function. Copper supports different cellular processes including mitochondrial metabolism and reactive oxygen species (ROS) balance. Deletion of CTR1 in CD4 T cells decreased intracellular copper levels, disrupting mitochondrial respiration and rewiring metabolism. These changes disrupted the epigenetic landscape of pTh17 cells by inducing DNA hypermethylation and altered chromatin accessibility, impairing transcription factor binding. As a result, CTR1-deficient T cells showed defective differentiation into pTh17 cells, with decreased production of IL-17A and expression of Th17 signature genes, while differentiation of other CD4 subsets remained unaffected. Moreover, T cell-specific deletion of CTR1 protected mice from EAE by suppressing clonal expansion of autoreactive CD4+ T cells and CNS inflammation. These findings establish copper as a critical regulator of pTh17 differentiation and function, revealing a previously unknown molecular link between copper homeostasis, metabolism and epigenetic regulation governing Th17-mediated autoimmunity. Colton Autoimmunity Center Immune Response Regulation: Molecular Mechanisms (IRM)

View source

Similar papers

Oct 2026

Metabolic reprogramming of pathogenic CD4+ T helper cells attenuates inflammatory bowel disease in mice.

CD4+ effector T helper 1 (TH1) cells drive inflammatory bowel disease (IBD). Here, we investigated how integrated signaling, metabolic, and epigenetic programs sustain their pathogenic persistence. We found that enforcing mitochondrial pyruvate metabolism with methyl pyruvate (MePyr) suppressed TH1 cell effector functi...

Shravan K. Mishra, Leena M. Abdelrahman, Hyun Se Kim Lee et al. · 0 citations
Open access Aug 2026

Unconventional role of hydroxymethylglutaryl-CoA synthase 1 in driving pathogenic TH17 cell immunity and autoimmune diseases

This work unveils a noncanonical axis in which HMGCS1 sustains ER stress to license pTH17 differentiation during autoimmune responses, and thereby unveils a noncanonical axis in which pTH17 immunity and mitigates autoimmune disease in vivo are revealed.

Jie Sun, Ya-Li Lei, Huan-Huan Yang et al. · 0 citations
Open access Sep 2026

T-Cell Specific Deletion of PTPN23 Alters T-Cell Development and TCRαβ/γδ Composition

Highlights What are the main findings? T-cell–specific deletion of PTPN23 causes a marked reduction in T-cells, accompanied by preferential accumulation of TCRγδ T-cells and enrichment of differentiated effector/memory T-cell subsets. Multi-omics and single-cell RNA sequencing reveal alterations in T-cell developmental...

Rocio Sanchez Alvarez, M. Determann, L. Linzmeier et al. · 0 citations
Review Open access Aug 2026

Metabolic switch: lymphocytes and the onset of T-cell-mediated autoimmunity

How changes in glucose, lipid, and mitochondrial metabolism influence immune responses that lead to chronic inflammation and autoimmunity in MS, RA, and T1D is discussed.

Andisheh Mosaffa Jahromi, Fatemeh Mirzaei, Sara Mirzazadeh et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.